CLPT Q2 2020 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena

CLPTClearPoint Neuro, Inc.

$344M

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2M-4.9% YoY

Gross Profit

$2M67.6% margin

Operating Income

-$1M-59.5% margin

Net Income

-$2M-67.0% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

-20.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$23M

Total Liabilities

$22M

Stockholders' Equity

$1M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-4.9%
Gross Profit	$2M	$2M	+6.3%
Operating Income	-$1M	-$1M	-14.1%
Net Income	-$2M	-$2M	-7.1%

Revenue Segments

Capital Equipment-Related Service Revenue

$89,000

Remaining Performance Obligations Capital Equipment-Related Service Revenue

-$320,000